News

Medsintez Plant participated in a key industry event, Product Innovation Fair in Medicine and Healthcare, which took place in Moscow on October 29–30. Viktor Fisenko, First Deputy Minister of Healthcare of Russia, attended the exhibition of domestic innovations in the field of drugs and medical products.

The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.

In September 2025, the Russian Ministry of Health issued a registration certificate for a new dosage form of the broad-spectrum antiviral drug TRIAZAVIRIN® for the treatment of ARVI in school-age children—100 mg.

On October 10, 2025, a representative delegation visited the Medsintez Plant. Among the visitors, there were members of the State Duma of the Russian Federation, representatives of the Government and Legislative Assembly of the Sverdlovsk Region, the head of the Novouralsk Urban District, and leading regional experts in the field of medical science. The main purpose of the visit was to assess the enterprise's success in import-substituting drug production, become familiar with its brand-new products, and discuss development options of the pharmaceutical industry in the region.

Current data on modern approaches to the therapy of acute respiratory viral infections (ARVI) in children were presented at the VI Congress of Children's Physicians of the Moscow Region with international participation «Pediatrics as an Art» (September 3–5, 2025). Zhdanov K. V., Doctor of Medical Sciences, Professor, Director of the Scientific and Clinical Center of the Federal State Budgetary Institution «Federal Scientific and Clinical Center of Infectious Diseases of the Federal Medical and Biological Agency of Russia», corresponding member of the Russian Academy of Sciences, and honored scientist of the Russian Federation, delivered a key report titled «Current Issues of the ARVI Therapy in Children. New Data.»

On September 3, 2025, Denis Pasler, Acting Governor of the Sverdlovsk Region, paid a working visit to Medsintez Plant LLC, one of the systemic companies of the Russian Federation. The purpose of the visit was to assess the scale of import substitution in pharmaceutical production, get acquainted with the latest developments of the plant, and discuss prospects for the regional pharmaceutical industry.

Experts from the Russian Ministry of Health have included the TRIAZAVIRIN® antiviral drug in the guidelines «Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection COVID-19» (version No. 19 dated 27/5/2025).

From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.

The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.

In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.

From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.

On April 6, the First Children's Polyclinic in the Akademichesky District celebrated its 10th anniversary. During this time, the institution has become a flagship of high-quality and affordable medical care for children, serving 33,083 young patients. The polyclinic was created by the initiative of the Ural Biomedical Cluster and the Governor of the Sverdlovsk Region and became a successful example of public-private partnership.

A meeting of the Committee on Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry was held in Ekaterinburg on March 18, 2025, chaired by Alexander Petrov. Participants of the event, including representatives of the Association of Medical Specialists for Risk Modification, the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, the Ural Biomedical Cluster and members of the Committee considered key challenges in maintaining the health of the able-bodied population, fighting against socially significant diseases and regulating prices for vital drugs.